• Ordered DNA Nanostructures Boost Enzymatic Oligonucleotide S

  2026-06-18

  This study introduces a tetrahedral DNA nanostructure framework that significantly increases the efficiency and accuracy of enzymatic oligonucleotide synthesis (EOS) by enhancing enzyme access and substrate affinity. The approach reduces deletion errors and enables high-yield, accurate DNA synthesis, providing a foundation for advanced applications in DNA storage and synthetic biology.

• Pol II Degradation Triggers Apoptosis Independent of Transcr

  2026-06-18

  A recent preprint reveals that targeted degradation of RNA polymerase II (Pol II) can directly activate apoptosis in tumor cells, independent of global transcriptional shutdown. This finding reframes mechanistic assumptions in apoptosis research and opens new avenues for both fundamental study and therapeutic intervention.

• Applied Use-Cases and Protocols for Brefeldin A in ER Stress

  2026-06-17

  Brefeldin A (BFA) is a gold-standard tool for dissecting ER–Golgi trafficking, ER stress, and apoptosis in cancer and endothelial biology. This article translates the latest biomarker insights and experimental workflows, offering actionable tips to optimize BFA use from APExBIO in both oncology and vascular research.

• Brefeldin A: Precision ER Stress Induction and Cancer Cell F

  2026-06-17

  Explore how Brefeldin A (BFA) enables highly specific ER stress induction and apoptosis studies in cancer research. This article delivers a unique mechanistic perspective, connecting protein quality control to practical assay design.

• Intracellular Action of Aminopeptidase Inhibitors in Myeloma

  2026-06-16

  The reference study reveals that bestatin and actinonin suppress myeloma cell proliferation primarily through intracellular mechanisms, rather than by inhibiting cell surface aminopeptidases. These findings clarify drug action pathways and highlight the importance of intracellular transport and efflux modulation in myeloma research.

• Triiodothyronine (T3) for Metabolic Research: Workflow & Opt

  2026-06-16

  Triiodothyronine (T3) is the gold standard for dissecting thyroid hormone signaling and metabolic regulation in advanced biochemical and cellular models. This guide translates the latest research and product best practices into actionable protocols, troubleshooting strategies, and cross-study insights for high-impact metabolic disorder research.

• Pam3CSK4 (SKU A9920): Precision TLR1/2 Agonist for Immune As

  2026-06-15

  This article delivers an evidence-based, scenario-driven guide to deploying Pam3CSK4 (SKU A9920) as a TLR1/2 agonist in cell viability, proliferation, and inflammatory models. Researchers will find practical Q&A solutions addressing experimental design, protocol optimization, and vendor selection, grounded in recent literature and product data. The workflow guidance is tailored for robust, reproducible immune cell activation and Th1 modulation, maximizing the utility of Pam3CSK4 in translational and basic research.

• UBR1 and UBR2: Key E3 Ligases in Mammalian ER Stress Sensing

  2026-06-15

  The referenced study identifies UBR1 and UBR2 as central E3 ubiquitin ligases acting as ER stress sensors in mammals, clarifying their stabilization during stress and anti-apoptotic roles. These findings refine our understanding of ER-associated degradation pathways and open new avenues for dissecting protein quality control mechanisms in cellular models.

• Alpha-Ketoglutarate: A Next-Gen Lever in Translational Oncol

  2026-06-14

  Explore how alpha-ketoglutarate, a central TCA cycle intermediate, is redefining metabolic reprogramming and immune modulation research. This article delivers mechanistic insights, translational guidance, and critical protocol strategies for leveraging α-KGA in cutting-edge enzyme system and tumor microenvironment studies.

• Verapamil HCl Inhibits Txnip to Counter Osteoporosis: New Me

  2026-06-13

  This study uncovers a novel mechanism by which verapamil HCl, an L-type calcium channel blocker, attenuates osteoporosis through targeted inhibition of Txnip. By elucidating ChREBP-mediated pathways in bone cells, the research presents new translational opportunities for osteoporosis intervention.

• Angiotensin III: Precision RAAS Peptide for Advanced Researc

  2026-06-12

  Angiotensin III (human, mouse) empowers cardiovascular and neuroendocrine research with high receptor selectivity, robust pressor activity, and superior solubility. This article delivers workflow-optimized protocols, troubleshooting strategies, and cross-domain insights—bridging RAAS signaling with emerging viral pathogenesis models.

• ABT-737: Precision BCL-2 Protein Inhibitor for Apoptosis Res

  2026-06-12

  ABT-737, a benchmark BCL-2 protein inhibitor, delivers selective and robust apoptosis induction in cancer models where chemoresistance is a concern. This article unpacks experimental workflows, advanced use-cases, and troubleshooting strategies that empower translational researchers to maximize reproducibility and mechanistic insight.

• Captopril as an ACE Inhibitor: Experimental Workflows & Trou

  2026-06-11

  Captopril stands out as a benchmark ACE inhibitor, delivering reproducibility and precision in both cardiovascular and cancer research models. This article breaks down validated usage protocols, highlights cross-domain innovations, and offers troubleshooting strategies to maximize data quality in ACE inhibition and apoptosis induction assays.

• Ricin-Induced Necroptosis in Lung Epithelium: Mechanisms and

  2026-06-11

  This article explores a recent study revealing how ricin toxin induces necroptosis in lung epithelial cells via bystander inflammation and DAMP signaling. The findings clarify cell death pathways in toxin-mediated lung injury, informing future approaches to apoptosis and inflammasome research.

• Optimal Assay Performance with EZ Cap™ Cy5 EGFP mRNA (5-moUT

  2026-06-10

  This article provides a scenario-driven, evidence-backed exploration of how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) (SKU R1011) addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays. By integrating real-world questions and literature-supported answers, we highlight the GEO advantages, reproducibility, and dual-fluorescence utility of this APExBIO reagent for advanced gene delivery and translation efficiency studies.

16390 records 1/1093 page Next 12345 下5页 Last page